Merck leans on a fast-growing pipeline and new product launches to aid long-term growth as Keytruda's 2028 LOE nears.

High-dose radiation with Keytruda led to increased infiltration of various immune cells and formation of tertiary lymphoid ...

The Munich Regional Court ruled there was imminent infringement for Merck & Co.’s Keytruda SC in Germany related to ...

MRK banks on Capvaxive, Winrevair and other new launches to counter Keytruda's looming 2028 LOE and record long-term growth.

Halozyme is seeing some progress in its global effort to defend intellectual property against alleged infringement by Merck & ...

The verdict is the latest twist in patent litigation between MSD and Halozyme, in which the latter is claiming that Keytruda ...

In a setback for Merck, a German court issued a preliminary injunction that prevents the company from distributing a new ...

Ahmedabad: Zydus Lifesciences Limited, a life-sciences company, with an international presence, has announced that its wholly ...

Formycon will develop, register, manufacture, and supply the product, while Zydus will be responsible for commercialization.

Zydus Lifesciences Limited (including its subsidiaries and affiliates), an innovation-led life-sciences company, with an ...

Formycon AG will be responsible for the development, registration, manufacture and supply of the product. Zydus Lifesciences ...

Under the terms of this agreement, Formycon AG will develop, register, manufacture and supply the product, while Zydus Lifesciences Global FZE, United Arab Emirates will be responsible for the ...